Latest News

New variant jumps to second place on COVID list


 

The new COVID-19 strain known as “Arcturus” has increased in the United States so much that it has been added to the Centers for Disease and Control’s watch list.

Officially labeled XBB.1.16, Arcturus is a subvariant of Omicron that was first seen in India and has been on the World Health Organization’s watchlist since the end of March. The CDC’s most recent update now lists Arcturus as causing 7% of U.S. coronavirus cases, landing it in second place behind its long-predominant Omicron cousin XBB.1.5, which causes 78% of cases.

Arcturus is more transmissible but not more dangerous than recent chart-topping strains, experts say.

“It is causing increasing case counts in certain parts of the world, including India. We’re not seeing high rates of XBB.1.16 yet in the United States, but it may become more prominent in coming weeks,” Mayo Clinic viral disease expert Matthew Binnicker, PhD, told The Seattle Times.

Arcturus has been causing a new symptom in children, Indian medical providers have reported.

“One new feature of cases caused by this variant is that it seems to be causing conjunctivitis, or red and itchy eyes, in young patients,” Dr. Binnicker said. “This is not something that we’ve seen with prior strains of the virus.”

More than 11,000 people in the United States remained hospitalized with COVID at the end of last week, and 1,327 people died of the virus last week, CDC data show. To date, 6.9 million people worldwide have died from COVID, the WHO says. Of those deaths, more than 1.1 million occurred in the U.S.

A version of this article originally appeared on WebMD.com.

Recommended Reading

COVID-19 potentially induced adult-onset IgA vasculitis
MDedge Internal Medicine
High-dose prophylactic anticoagulation benefits patients with COVID-19 pneumonia
MDedge Internal Medicine
Nasal COVID treatment shows early promise against multiple variants
MDedge Internal Medicine
Negative expectations of COVID shots may amplify side effects
MDedge Internal Medicine
Single bivalent COVID booster is enough for now: CDC
MDedge Internal Medicine
Doctor’s checklist for treating long COVID patients
MDedge Internal Medicine
Long COVID hitting some states, minorities, women harder
MDedge Internal Medicine
Long COVID: ‘On par’ with heart disease, cancer, book says
MDedge Internal Medicine
COVID caused 4.6-year drop in NYC life expectancy
MDedge Internal Medicine
As COVID tracking wanes, are we letting our guard down too soon?
MDedge Internal Medicine